These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 191408)
21. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis. Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384 [TBL] [Abstract][Full Text] [Related]
22. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters. Nikoskelainen J; Ablashi DV; Isenberg RA; Neel EU; Miller RG; Stevens DA J Immunol; 1978 Oct; 121(4):1239-44. PubMed ID: 81224 [TBL] [Abstract][Full Text] [Related]
23. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6. Lennette ET; Rymo L; Yadav M; Masucci G; Merk K; Timar L; Klein G Eur J Cancer; 1993; 29A(11):1584-9. PubMed ID: 8217366 [TBL] [Abstract][Full Text] [Related]
24. Humoral antibodies to the capsid antigen of Epstein-Barr virus in Hodgkin's disease. Stepina VN; Gourtsevicz VE; Mazurenko NP; Yarymova NM; Kaverznyeva MM; Lorye YI Neoplasma; 1976; 23(5):523-32. PubMed ID: 185535 [TBL] [Abstract][Full Text] [Related]
26. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site. Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852 [TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus antibody in childhood Hodgkin's disease. Shope TC; Khalifa AS; Smith ST; Cushing B Am J Dis Child; 1982 Aug; 136(8):701-3. PubMed ID: 6285693 [TBL] [Abstract][Full Text] [Related]
28. Parallel tubular structures in lymphocytes. II. Correlation with cellular immunity and cytomegalovirus and Epstein-Barr virus antibodies in Hodgkin's disease. Halie MR; Langenhuysen MM; de Gast GC; Nieweg HO Acta Haematol; 1975; 54(2):82-8. PubMed ID: 169660 [TBL] [Abstract][Full Text] [Related]
29. The relation between Epstein-Barr virus antibodies and clinical symptomatology and immunodeficiency in patients with Hodgkin's disease. Mochanko K; Fejes M; Breazavscek DM; Suarez A; Bachmann AE Cancer; 1979 Dec; 44(6):2065-70. PubMed ID: 228834 [TBL] [Abstract][Full Text] [Related]
30. [Immunology of Epstein-Barr virus in lymphoproliferative diseases]. Bachmann AE; Giraudo Conesa LC; Braun M Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156 [No Abstract] [Full Text] [Related]
31. EB virus-specific IgA in serum of patients with infectious mononucleosis and of healthy people of different ages. Edwards JM; Woodroof M J Clin Pathol; 1979 Oct; 32(10):1036-40. PubMed ID: 230203 [TBL] [Abstract][Full Text] [Related]
32. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus. Yang CS; Hewetson JF Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526 [No Abstract] [Full Text] [Related]
33. Hodgkin's disease and infectious mononucleosis. Green JA; Dawson AA; Valerio D Scand J Haematol; 1979 Oct; 23(4):313-4. PubMed ID: 231818 [TBL] [Abstract][Full Text] [Related]
34. The Epstein-Barr virus (EBV) in human pathology. Results of a serological investigation of a hospital population. Dalens M; Didier J; Pris J; Enjalbert L Biomedicine; 1973 Jul; 18(4):336-45. PubMed ID: 4139980 [No Abstract] [Full Text] [Related]
35. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients. Cao P; Zhang M; Wang W; Dai Y; Sai B; Sun J; Wang L; Wang F; Li G; Xiang J BMC Infect Dis; 2017 May; 17(1):323. PubMed ID: 28468603 [TBL] [Abstract][Full Text] [Related]
36. Epstein Barr virus (EBV) carrying cells in blood of Hodgkin's disease (HD) and non-Hodgkin lymphoma (NHL) patients with high antibody titers against EBV capsid antigens (VCA). Lewin N; Aman P; Mellstedt H; Carenfelt C; Klein G; Klein E Anticancer Res; 1990; 10(5A):1213-6. PubMed ID: 2173472 [TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus (EBV)-associated antibody patterns in relation to the deficiency of cell-mediated immunity in patients with Hodgkin's disease. Johansson B; Killander D; Holm G; Mellstedt H; Henle G; Henle W; Klein G; Söderberg G IARC Sci Publ (1971); 1975; (11 Pt 2):237-47. PubMed ID: 191367 [TBL] [Abstract][Full Text] [Related]
38. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis. Royston I; Sullivan JL; Periman PO; Perlin E N Engl J Med; 1975 Dec; 293(23):1159-63. PubMed ID: 171568 [TBL] [Abstract][Full Text] [Related]
39. Analysis of Epstein-Barr virus-specific and non-specific immune functions in a patient during the development of a non-Hodgkin's lymphoma. Masucci G; Mellstedt H; Masucci MG; Ernberg I; Szigeti R; Henle G; Henle W; Klein G Eur J Cancer Clin Oncol; 1987 Apr; 23(4):379-86. PubMed ID: 3038561 [TBL] [Abstract][Full Text] [Related]
40. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses. Szigeti R; Rabin H; Timar L; Klein G Intervirology; 1986; 26(3):121-8. PubMed ID: 3034820 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]